Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Orbis Medicines secures €90M Series A to develop innovative oral macrocycles, offering cost-effective alternatives to ...

A groundbreaking therapy first introduced by Northwestern University researchers in 2021 has shown promise in regenerating ...

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Researchers have uncovered a hierarchical structure of immune-privileged stem cells in bone marrow niches, revealing their ...

UNIST researchers reveal blue lights new pathway damaging cellular proteins New study uncovers novel mechanism by which blue ...

An innovative technique, termed the 'molecular lantern', enables non-invasive monitoring of molecular changes in the brain, ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...